InvestorsHub Logo
Followers 62
Posts 1712
Boards Moderated 0
Alias Born 08/08/2005

Re: None

Friday, 08/10/2007 4:57:18 PM

Friday, August 10, 2007 4:57:18 PM

Post# of 346054
Peregrine doesn’t seem to like anything, if there has been anything, offered around bavituximab; or Cotara or…; so far. Too bad, I’d like to see a medium sized deal that would provide operating capital for the core technologies. There are trials in progress. I think the July 23rd DTRA news is an important marker.

Peregrine knows the value of this platform, and is confident that it can be realized. We’ve heard them say that it will take phase 2 data. BP is not going to offer full value with less than 100 bavi patients treated so far. They can wait; Peregrine will wait.

sunstar






Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News